Inhibrx is transitioning from a platform to a clinical-stage biotech, with ozekibart and INBRX-106 as key value drivers.
Glioblastoma is an aggressive brain cancer with low survival rates due to the blood brain barrier blocking many chemotherapy ...
The Edwardsville Intelligencer on MSN
Edwardsville teacher finds community support during cancer treatment
"It's going to be a long road, but travel is easy with friends." Keith Baker says.
An artist who thought they were suffering from a simple earache died just weeks later after a nightmare diagnosis. In January ...
A woman with an aggressive form of brain cancer has sold her house to pay for potentially life-extending treatment that is ...
An artist who thought they were suffering from a simple earache died just weeks later after a nightmare diagnosis. In January ...
It has lead programmes in endometriosis and chemotherapy induced peripheral neuropathy (CIPN). The directors are thrilled to announce the first patient has been dosed in the ACTiON clinical trial ...
A woman with an aggressive form of brain cancer sold her house to pay for potentially life-extending treatment which is ...
Cancer treatments like radiation and chemotherapy work by doing one main thing: shredding the DNA of cancer cells so they can no longer multiply.
Loss of one copy of the DNA Ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations confers ...
Medulloblastoma is the most common malignant embryonal tumor of the central nervous system in the pediatric population, ...
Aly Well, a 19-year-old who just completed her last round of chemotherapy, was unable to ring an end-of-treatment bell, so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results